TIBER CREEK GROUP

Lobbying for ACADIA PHARMACEUTICALS, INC. · Biopharmaceutical company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $80,000.00 income · posted Jul 19, 2026

Lobbying activity 1

Health Issues

Issues related to drug pricing; Issues related to the Inflation Reduction Act (PL 117-169).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.